The Private-Label Grocery Market

In 2021, overall private-label brand dollar share grew 1% and hit a record $199 billion in all U.S. retail channels. Phillip Russo, Founder of Global Retail Brands Magazine, tracks the trends in the private-label market. He spoke with Christine Russo, the host of What Just Happened, on the factors leading to the growth of private-label brands in the grocery market.

Private-label brands are on the rise in the grocery market, and it’s not simply inflation and rising costs driving private labels. 55% of consumers say they buy private labels because they are less expensive. Still, quality, taste, sustainability, health, and well- being are also driving purchases. According to Russo, private labels are growing regardless of global macroeconomic factors.

Why are private-label brands doing so well?

“One of the most important aspects of a retailer using a private label is that the margins are considerably higher,” Russo said. “The flip side is the volume may not be as high. So, it’s really a question of what the retailer is looking to accomplish. But I would say the chief reason why it’s important to retailers is that it allows them to reach their customers with the right product following whatever trend may be important sooner than the national brand.”

Russo and Russo discuss several critical issues in private-label grocery…

● Examples of crucial grocery retailer private-label brands that are critical to the growth and success of the business

● The businesses that supply global grocery private-label brands

● How independent products get to market with larger grocery retailers

“Retailers are constantly looking for what’s new,” Russo said. “I mean, let’s face it; consumers can get bored quickly, and there’s nothing that moves things better than new innovation, following trends, and the little companies tend to bring this to market.”

Phillip Russo’s involvement in media and retail brands is a thirty-year journey, working for Miller Freeman, Dwell Magazine, and Private Label Magazine. He is the owner, publisher, and editor of Global Retail Brands Magazine, founded in 2012. Global Retail Brands delivers content via print, digital, and social outlets. It promotes best practices in all retail channels that emphasize private labels.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More